NCT00002231View on ClinicalTrials.gov

Safety and Effects of Giving a New HIV Vaccine (GENEVAX-HIV) to HIV-Negative Volunteers

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

Not specified

Conditions

HIV InfectionsHIV Seronegativity

Interventions

BIOLOGICAL

APL 400-003

Trial Locations (1)

19104

Univ of Pennsylvania Med Ctr, Philadelphia

All Listed Sponsors

lead

Wyeth-Lederle Vaccines

INDUSTRY

NCT00002231 - Safety and Effects of Giving a New HIV Vaccine (GENEVAX-HIV) to HIV-Negative Volunteers | Biotech Hunter | Biotech Hunter